Aspira Women's Health Files S-1/A Amendment
Ticker: AWHL · Form: S-1/A · Filed: 2025-05-01T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, s-1/a, amendment
Related Tickers: AWH
TL;DR
Aspira Women's Health (AWH) filed an S-1/A, likely for a stock offering. Watch closely.
AI Summary
Aspira Women's Health Inc. filed an S-1/A amendment on May 1, 2025, related to its public offering. The company, formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc., is based in Austin, TX, and operates in the in vitro & in vivo diagnostic substances sector.
Why It Matters
This filing indicates Aspira Women's Health is actively pursuing capital raising or other significant corporate actions, which could impact its stock price and future operations.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to stock offerings or significant corporate changes, which carry inherent market risks.
Key Numbers
- 20250501 — Filing Date (Indicates the date of the S-1/A amendment filing.)
- 2024-12-31 — Fiscal Year End (Shows the company's fiscal year concludes on December 31st.)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer
- 0000926617 (company) — Central Index Key
- VERMILLION, INC. (company) — Former Company Name
- CIPHERGEN BIOSYSTEMS INC (company) — Former Company Name
- AUSTIN, TX (company) — Business Address City and State
- 512-519-0400 (company) — Business Phone Number
FAQ
What is the primary purpose of this S-1/A filing?
The S-1/A filing is an amendment to a registration statement, typically used for public offerings of securities or significant corporate changes, though the specific details are not provided in this header information.
When was Aspira Women's Health Inc. previously known by other names?
Aspira Women's Health Inc. was formerly known as VERMILLION, INC. (name change effective 20070824) and CIPHERGEN BIOSYSTEMS INC (name change effective 20000316).
What is the company's primary industry classification?
The company is classified under 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' with SIC code [2835].
Where is Aspira Women's Health Inc. located?
The company's business and mailing address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738.
What is the SEC file number associated with this filing?
The SEC file number for this filing is 333-286561.
From the Filing
0001641172-25-007948.txt : 20250501 0001641172-25-007948.hdr.sgml : 20250501 20250430201019 ACCESSION NUMBER: 0001641172-25-007948 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 76 FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-286561 FILM NUMBER: 25898763 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 S-1/A 1 forms-1a.htm S-1/A true 0000926617 S-1/A http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense 0000926617 2024-01-01 2024-12-31 0000926617 dei:BusinessContactMember 2024-01-01 2024-12-31 0000926617 2024-12-31 0000926617 2023-12-31 0000926617 2023-01-01 2023-12-31 0000926617 us-gaap:ProductMember 2024-01-01 2024-12-31 0000926617 us-gaap:ProductMember 2023-01-01 2023-12-31 0000926617 AWH:GeneticsMember 2024-01-01 2024-12-31 0000926617 AWH:GeneticsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-12-31 0000926617 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000926617 us-gaap:CommonStockMember 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:WarrantInducementAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:WarrantInducementAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2023-01-01 2023-12-31 0000926617 2024-07-01 0000926617 2024-10-17 0000926617 us-gaap:SubsequentEventMember 2025-02-11 0000926617 srt:MaximumMember 2024-12-31 0000926617 srt:MinimumMember 2024-12-31 0000926617 srt:Maximum